vs

Side-by-side financial comparison of Identiv, Inc. (INVE) and Precipio, Inc. (PRPO). Click either name above to swap in a different company.

Precipio, Inc. is the larger business by last-quarter revenue ($6.8M vs $6.2M, roughly 1.1× Identiv, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -60.3%, a 68.1% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -7.9%). Identiv, Inc. produced more free cash flow last quarter ($2.8M vs $291.0K). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -3.8%).

Identiv is a publicly traded Internet of Things technology company listed on the Nasdaq stock market.

Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.

INVE vs PRPO — Head-to-Head

Bigger by revenue
PRPO
PRPO
1.1× larger
PRPO
$6.8M
$6.2M
INVE
Growing faster (revenue YoY)
PRPO
PRPO
+36.4% gap
PRPO
28.4%
-7.9%
INVE
Higher net margin
PRPO
PRPO
68.1% more per $
PRPO
7.7%
-60.3%
INVE
More free cash flow
INVE
INVE
$2.5M more FCF
INVE
$2.8M
$291.0K
PRPO
Faster 2-yr revenue CAGR
PRPO
PRPO
Annualised
PRPO
40.0%
-3.8%
INVE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INVE
INVE
PRPO
PRPO
Revenue
$6.2M
$6.8M
Net Profit
$-3.7M
$526.0K
Gross Margin
18.1%
45.9%
Operating Margin
-76.4%
7.9%
Net Margin
-60.3%
7.7%
Revenue YoY
-7.9%
28.4%
Net Profit YoY
-948.2%
244.1%
EPS (diluted)
$-0.17
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INVE
INVE
PRPO
PRPO
Q4 25
$6.2M
$6.8M
Q3 25
$5.0M
$6.9M
Q2 25
$5.0M
$5.6M
Q1 25
$5.3M
$4.9M
Q4 24
$6.7M
$5.3M
Q3 24
$6.5M
$5.3M
Q2 24
$6.7M
$4.5M
Q1 24
$6.7M
$3.5M
Net Profit
INVE
INVE
PRPO
PRPO
Q4 25
$-3.7M
$526.0K
Q3 25
$-3.5M
$-79.0K
Q2 25
$-6.0M
$74.0K
Q1 25
$-4.8M
$-884.0K
Q4 24
$-355.0K
$-365.0K
Q3 24
$85.9M
$-626.0K
Q2 24
$-6.2M
$-1.2M
Q1 24
$-4.6M
$-2.1M
Gross Margin
INVE
INVE
PRPO
PRPO
Q4 25
18.1%
45.9%
Q3 25
10.7%
43.6%
Q2 25
-9.4%
43.2%
Q1 25
2.5%
43.6%
Q4 24
-14.9%
49.8%
Q3 24
3.6%
43.1%
Q2 24
9.1%
38.1%
Q1 24
7.3%
26.5%
Operating Margin
INVE
INVE
PRPO
PRPO
Q4 25
-76.4%
7.9%
Q3 25
-111.4%
-0.9%
Q2 25
-126.7%
-14.6%
Q1 25
-103.8%
-17.5%
Q4 24
-98.9%
-6.3%
Q3 24
-146.2%
-11.3%
Q2 24
-99.7%
-26.8%
Q1 24
-76.0%
-59.6%
Net Margin
INVE
INVE
PRPO
PRPO
Q4 25
-60.3%
7.7%
Q3 25
-68.9%
-1.1%
Q2 25
-119.9%
1.3%
Q1 25
-90.9%
-18.0%
Q4 24
-5.3%
-6.9%
Q3 24
1315.8%
-11.9%
Q2 24
-92.2%
-27.1%
Q1 24
-68.5%
-59.8%
EPS (diluted)
INVE
INVE
PRPO
PRPO
Q4 25
$-0.17
$0.36
Q3 25
$-0.15
$-0.05
Q2 25
$-0.26
$0.05
Q1 25
$-0.21
$-0.59
Q4 24
$0.00
$-0.22
Q3 24
$3.62
$-0.42
Q2 24
$-0.27
$-0.83
Q1 24
$-0.21
$-1.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INVE
INVE
PRPO
PRPO
Cash + ST InvestmentsLiquidity on hand
$128.6M
$2.7M
Total DebtLower is stronger
$83.0K
Stockholders' EquityBook value
$140.7M
$14.6M
Total Assets
$151.3M
$21.3M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INVE
INVE
PRPO
PRPO
Q4 25
$128.6M
$2.7M
Q3 25
$126.3M
$2.3M
Q2 25
$129.3M
$1.1M
Q1 25
$132.4M
$1.0M
Q4 24
$135.6M
$1.4M
Q3 24
$145.4M
$1.1M
Q2 24
$18.4M
$1.3M
Q1 24
$21.6M
$776.0K
Total Debt
INVE
INVE
PRPO
PRPO
Q4 25
$83.0K
Q3 25
Q2 25
Q1 25
Q4 24
$383.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
INVE
INVE
PRPO
PRPO
Q4 25
$140.7M
$14.6M
Q3 25
$143.7M
$13.7M
Q2 25
$146.4M
$12.3M
Q1 25
$150.5M
$11.7M
Q4 24
$154.1M
$12.1M
Q3 24
$156.7M
$11.9M
Q2 24
$65.1M
$12.1M
Q1 24
$70.2M
$12.8M
Total Assets
INVE
INVE
PRPO
PRPO
Q4 25
$151.3M
$21.3M
Q3 25
$151.0M
$21.2M
Q2 25
$153.9M
$18.8M
Q1 25
$158.7M
$17.8M
Q4 24
$163.2M
$17.0M
Q3 24
$177.0M
$17.0M
Q2 24
$97.8M
$17.3M
Q1 24
$101.8M
$16.6M
Debt / Equity
INVE
INVE
PRPO
PRPO
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INVE
INVE
PRPO
PRPO
Operating Cash FlowLast quarter
$3.0M
$366.0K
Free Cash FlowOCF − Capex
$2.8M
$291.0K
FCF MarginFCF / Revenue
45.8%
4.3%
Capex IntensityCapex / Revenue
3.3%
1.1%
Cash ConversionOCF / Net Profit
0.70×
TTM Free Cash FlowTrailing 4 quarters
$-7.8M
$359.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INVE
INVE
PRPO
PRPO
Q4 25
$3.0M
$366.0K
Q3 25
$-2.9M
$10.0K
Q2 25
$-3.6M
$353.0K
Q1 25
$-3.3M
$-44.0K
Q4 24
$-5.9M
$565.0K
Q3 24
$-7.2M
$41.0K
Q2 24
$-993.0K
$500.0K
Q1 24
$-1.3M
$-667.0K
Free Cash Flow
INVE
INVE
PRPO
PRPO
Q4 25
$2.8M
$291.0K
Q3 25
$-3.2M
$-44.0K
Q2 25
$-3.8M
$294.0K
Q1 25
$-3.6M
$-182.0K
Q4 24
$-6.5M
Q3 24
$-7.7M
$-68.0K
Q2 24
$-1.1M
Q1 24
$-1.5M
FCF Margin
INVE
INVE
PRPO
PRPO
Q4 25
45.8%
4.3%
Q3 25
-64.5%
-0.6%
Q2 25
-75.8%
5.2%
Q1 25
-68.0%
-3.7%
Q4 24
-97.7%
Q3 24
-118.2%
-1.3%
Q2 24
-16.7%
Q1 24
-23.0%
Capex Intensity
INVE
INVE
PRPO
PRPO
Q4 25
3.3%
1.1%
Q3 25
7.0%
0.8%
Q2 25
5.0%
1.0%
Q1 25
5.7%
2.8%
Q4 24
9.3%
Q3 24
7.7%
2.1%
Q2 24
2.0%
Q1 24
3.5%
Cash Conversion
INVE
INVE
PRPO
PRPO
Q4 25
0.70×
Q3 25
Q2 25
4.77×
Q1 25
Q4 24
Q3 24
-0.08×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INVE
INVE

Other$3.4M55%
Europe And Middle East$2.2M36%
Asia Pacific$575.0K9%

PRPO
PRPO

Segment breakdown not available.

Related Comparisons